» Articles » PMID: 19076445

Mitochondrial and Nuclear Cross Talk in Cell Death: Parthanatos

Overview
Specialty Science
Date 2008 Dec 17
PMID 19076445
Citations 187
Authors
Affiliations
Soon will be listed here.
Abstract

Poly(ADP-ribose) polymerase-1 (PARP-1) is an abundant nuclear protein best known to facilitate DNA base excision repair. Recent work has expanded the physiologic functions of PARP-1, and it is clear that the full range of biologic actions of this important protein are not yet fully understood. Regulation of the product of PARP-1, poly(ADP-ribose) (PAR), is a dynamic process with PAR glycohydrolase playing the major role in the degradation of the polymer. Under pathophysiologic situations overactivation of PARP-1 results in unregulated PAR synthesis and widespread neuronal cell death. Once thought to be necrotic cell death resulting from energy failure, we have found that PARP-1-dependent cell death is dependent on the generation of PAR, which triggers the nuclear translocation of apoptosis-inducing factor resulting in caspase-independent cell death. This form of cell death is distinct from apoptosis, necrosis, or autophagy and is termed parthanatos. PARP-1-dependent cell death has been implicated in tissues throughout the body and in diseases afflicting hundreds of millions worldwide, including stroke, Parkinson's disease, heart attack, diabetes, and ischemia reperfusion injury in numerous tissues. The breadth of indications for PARP-1 injury make parthanatos a clinically important form of cell death to understand and control.

Citing Articles

Biological characteristics, immune infiltration and drug prediction of PANoptosis related genes and possible regulatory mechanisms in inflammatory bowel disease.

Zhang M, Liu T, Luo L, Xie Y, Wang F Sci Rep. 2025; 15(1):2033.

PMID: 39814753 PMC: 11736032. DOI: 10.1038/s41598-024-84911-1.


Mechanisms and cross-talk of regulated cell death and their epigenetic modifications in tumor progression.

He R, Liu Y, Fu W, He X, Liu S, Xiao D Mol Cancer. 2024; 23(1):267.

PMID: 39614268 PMC: 11606237. DOI: 10.1186/s12943-024-02172-y.


NAD enhancers as therapeutic agents in the cardiorenal axis.

Marin-Blazquez M, Rovira J, Ramirez-Bajo M, Zapata-Perez R, Rabadan-Ros R Cell Commun Signal. 2024; 22(1):537.

PMID: 39516787 PMC: 11546376. DOI: 10.1186/s12964-024-01903-4.


Suppression of JNK pathway protects neurons from oxidative injury via attenuating parthanatos in glutamate-treated HT22 neurons.

Zhang W, Sun H, Zhao W, Li J, Meng H Sci Rep. 2024; 14(1):25793.

PMID: 39468165 PMC: 11519538. DOI: 10.1038/s41598-024-76640-2.


A disulfidptosis-related lncRNA signature for analyzing tumor microenvironment and clinical prognosis in hepatocellular carcinoma.

Zheng H, Cheng J, Zhuang Z, Li D, Yang J, Yuan F Front Immunol. 2024; 15:1412277.

PMID: 39434887 PMC: 11491388. DOI: 10.3389/fimmu.2024.1412277.


References
1.
DAmours D, Desnoyers S, DSilva I, Poirier G . Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem J. 1999; 342 ( Pt 2):249-68. PMC: 1220459. View

2.
Cosi C, Guerin K, Marien M, Koek W, Rollet K . The PARP inhibitor benzamide protects against kainate and NMDA but not AMPA lesioning of the mouse striatum in vivo. Brain Res. 2003; 996(1):1-8. DOI: 10.1016/j.brainres.2003.09.072. View

3.
Crompton M, Barksby E, Johnson N, Capano M . Mitochondrial intermembrane junctional complexes and their involvement in cell death. Biochimie. 2002; 84(2-3):143-52. DOI: 10.1016/s0300-9084(02)01368-8. View

4.
Mandir A, Poitras M, Berliner A, Herring W, Guastella D, Feldman A . NMDA but not non-NMDA excitotoxicity is mediated by Poly(ADP-ribose) polymerase. J Neurosci. 2000; 20(21):8005-11. PMC: 6772735. View

5.
Genovese T, Mazzon E, Muia C, Patel N, Threadgill M, Bramanti P . Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and secondary damage in experimental spinal cord trauma. J Pharmacol Exp Ther. 2004; 312(2):449-57. DOI: 10.1124/jpet.104.076711. View